ImmunoGenesis Expands R&D, Clinical and Business Development Teams and Opens Research Laboratory
Clinical and CMC hires to ready initiation of multiple immuno-oncology clinical programs in 2022
Proven business development expertise key to executing global clinical development strategy
R&D hires and lab opening to facilitate critical translational research